Plasma therapy not effective, likely to be dropped from clinical management guidelines on Covid-19

The ICMR-National Covid-19 Task Force unanimously agreed to remove the use of convalescent plasma from the Clinical Guidance for Management of Adult Covid-19 Patients, citing its ineffectiveness and inappropriate use in several cases.

Plasma therapy on Covid-19 patients has not been found effective in reducing the progression to severe disease or death and is likely to be dropped from the clinical management guidelines, sources said. In a meeting of the ICMR-National Task Force for Covid-19 on Friday, all members were in favour of removing the use of convalescent plasma from the Clinical Guidance for Management of Adult Covid-19 Patients citing its ineffectiveness and inappropriate use in several cases, they said.